Data on hyperkalemia frequency among chronic kidney disease (CKD) patients receiving renin-angiotensin aldosterone system inhibitors (RAASis) and its impact on subsequent RAASi treatment are limited.

Figshare2019-03-07 更新10

Rapid Ventricular Tachycardias Associated with Cilostazol Use

药物不良反应监测

心血管事件风险

A 92-year-old woman with normal systolic function had recently begun using the newly approved phosphodiesterase III inhibitor cilostazol when she was admitted with lower-extremity pain. Cilostazol is

PubMed Central30

Overall summary of adverse events (treated set).

药物不良反应监测

临床试验安全性分析

aPatients were randomised 2:2:1 to the tiotropium Respimat 5 μg, tiotropium Respimat 2.5 μg and placebo Respimat groups, respectively. bAs determined by the investigator. cElevation of aspartate amino

NIAID Data Ecosystem20

Cannabis related to adverse drug reactions and adverse effects.

资源简介：

相关数据集